DK0832186T3 - Erstatningsterapi til dental caries - Google Patents

Erstatningsterapi til dental caries

Info

Publication number
DK0832186T3
DK0832186T3 DK96918381T DK96918381T DK0832186T3 DK 0832186 T3 DK0832186 T3 DK 0832186T3 DK 96918381 T DK96918381 T DK 96918381T DK 96918381 T DK96918381 T DK 96918381T DK 0832186 T3 DK0832186 T3 DK 0832186T3
Authority
DK
Denmark
Prior art keywords
dental caries
replacement therapy
recombinant
mutans strains
production
Prior art date
Application number
DK96918381T
Other languages
Danish (da)
English (en)
Inventor
Jeffrey D Hillman
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of DK0832186T3 publication Critical patent/DK0832186T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
DK96918381T 1995-06-07 1996-06-07 Erstatningsterapi til dental caries DK0832186T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/486,037 US5607672A (en) 1995-06-07 1995-06-07 Replacement therapy for dental caries
PCT/US1996/009667 WO1996040865A1 (fr) 1995-06-07 1996-06-07 Therapie de substitution pour caries dentaires

Publications (1)

Publication Number Publication Date
DK0832186T3 true DK0832186T3 (da) 2003-12-01

Family

ID=23930361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918381T DK0832186T3 (da) 1995-06-07 1996-06-07 Erstatningsterapi til dental caries

Country Status (15)

Country Link
US (1) US5607672A (fr)
EP (1) EP0832186B1 (fr)
JP (1) JP4027970B2 (fr)
CN (1) CN1149280C (fr)
AT (1) ATE248216T1 (fr)
AU (1) AU702384B2 (fr)
BR (1) BR9609041A (fr)
CA (1) CA2223906C (fr)
DE (1) DE69629689T2 (fr)
DK (1) DK0832186T3 (fr)
ES (1) ES2205038T3 (fr)
NZ (1) NZ310289A (fr)
PT (1) PT832186E (fr)
RU (1) RU2224794C2 (fr)
WO (1) WO1996040865A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964760B2 (en) 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US5932469A (en) 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
US6475771B1 (en) 1997-06-10 2002-11-05 University Of Florida Research Foundation Antimicrobial polypeptides and methods of use
US6218362B1 (en) 1997-09-08 2001-04-17 Universite Laval Lantibiotic from Streptococcus mutans and uses thereof
DE10108900B4 (de) 2001-02-23 2005-03-10 3M Espe Ag Ermittlung des patientenbezogenen Kariesrisikos
EP1287745A1 (fr) 2001-08-24 2003-03-05 The Procter & Gamble Company Composition masicatoire avec des substances probiotiques
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
KR101176660B1 (ko) * 2003-08-11 2012-08-23 오라제닉스, 인코포레이티드 구강 건강의 유지를 위한 조성물 및 방법
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
US9968526B1 (en) 2005-01-24 2018-05-15 Dental Alliance Holdings, Lll System for caries management by risk assessment
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
CA2636236C (fr) * 2006-01-04 2016-08-16 Maude Wikstroem Produit probiotique pour l'amelioration de l'hygiene orale
US9427384B2 (en) 2006-01-23 2016-08-30 Dental Alliance Holdings, Llc System for caries management by risk assessment
US10143633B2 (en) 2006-10-16 2018-12-04 Dental Alliance Holdings, Llc Treating cariogenic diseased oral biofilm with elevated pH
ES2606349T3 (es) 2008-06-13 2017-03-23 Oragenics, Inc. Uso de bacterias productoras de peróxido de hidrógeno para el blanqueamiento de los dientes
EP3181682B1 (fr) 2008-09-29 2021-04-21 Intrexon Actobiotics NV Colonisation réduite de microbes au niveau de la muqueuse
MX343566B (es) * 2010-08-31 2016-11-09 Centro Superior De Investig En Salud Publica (Csisp) * Composiciones y probioticos/prebioticos anticaries.
JP2019529344A (ja) 2016-07-15 2019-10-17 イントレキソン コーポレーション ランチビオティックバリアントおよびその使用
AU2018379996A1 (en) 2017-12-05 2020-06-25 BioPlx, Inc. Methods and compositions to prevent microbial infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324860A (en) * 1978-02-23 1982-04-13 Forsyth Dental Infirmary For Children Lactate dehydrogenase mutants of Streptococcus mutans
US4133875A (en) * 1978-02-23 1979-01-09 Forsyth Dental Infirmary For Children Method of controlling dental caries with streptococcus mutans mutant strains

Also Published As

Publication number Publication date
JPH11507228A (ja) 1999-06-29
BR9609041A (pt) 1999-12-14
DE69629689T2 (de) 2004-06-17
JP4027970B2 (ja) 2007-12-26
US5607672A (en) 1997-03-04
EP0832186B1 (fr) 2003-08-27
AU702384B2 (en) 1999-02-18
MX9709598A (es) 1998-06-30
EP0832186A4 (fr) 2002-03-06
CA2223906A1 (fr) 1996-12-19
CN1149280C (zh) 2004-05-12
CA2223906C (fr) 2010-04-20
RU2224794C2 (ru) 2004-02-27
NZ310289A (en) 2000-02-28
ES2205038T3 (es) 2004-05-01
ATE248216T1 (de) 2003-09-15
WO1996040865A1 (fr) 1996-12-19
EP0832186A1 (fr) 1998-04-01
HK1015410A1 (en) 1999-10-15
DE69629689D1 (de) 2003-10-02
PT832186E (pt) 2004-01-30
CN1192234A (zh) 1998-09-02
AU6105996A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
DK0832186T3 (da) Erstatningsterapi til dental caries
BG100960A (bg) Дозирани форми с контролирано освобождаване на азитромицин
AU2001253038A1 (en) Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
EG21210A (en) Process for preparing of antiseptic dentifrice
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
BG101949A (bg) Диспергируема частичкова система за десензибилизиране на зъби
AU8658298A (en) Method for preventing and treating hearing loss using a neurturin protein product
CA2253287A1 (fr) Procede pour produire un polypeptide recombine comprenant l'addition d'un inhibiteur de proteases metal-dependantes ou de chymotrypsines au milieu de culture cellulaire
PL320484A1 (en) Method of treating diabetes using kgf
AU6857887A (en) Therapeutic agent
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DK0795604T3 (da) Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse
AU5323396A (en) Methods of treating inflammation and compositions therefor
AU6051898A (en) Facilitation of wound healing with cm101/gbs toxin
AU1781495A (en) Vaccine for nontypable haemophilus influenzae strain
DE69921330D1 (de) Nicht-virulente porphyromonas gingivalis mutante
WO2001083722A3 (fr) Enzymes therapeutiques, et methodes de traitement du mps-vi et de lignees de cellules en vue de l'obtention de ces enzymes par recombinaison
ATE210460T1 (de) Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben
DE50206172D1 (de) Heil-und pflegemittel auf sauerteigbasis sowie verfahren zu seiner herstellung
EP0904094A4 (fr) Traitement de maladies osseuses au moyen d'adrenomedulline
AU2002232755A1 (en) Felodipine transdermal device and methods
UA7955A (uk) Спосіб лікування туберкульозу легенів
UA15180A (uk) Спосіб коhсервативhого лікуваhhя геhералізоваhого пародоhтиту
MY104077A (en) Oral compositions